心室辅助装置（VAD）是机械循环支持（MCS）的一种重要类型，能够辅助心脏将血液泵送到全身，根据临床应用场景的不同，VAD可分为临时性装置和耐久性装置。耐久性VAD为植入式心室辅助装置（为植入式人工心脏主要代表），可满足患者长期的循环辅助需求，既可作为桥接到心脏移植或心功能康复的过渡治疗，也可作为长期治疗方案代替心脏功能。2019年到2024年，受新冠疫情影响，全球植入式心室辅助装置市场规模保持在了10亿美元左右的水平上。2020年到2024年，我国植入式心室辅助装置市场规模从100万人民币增加到2.6亿人民币，期间年复合增长率为339.8%。预计2033年我国植入式心室辅助装置市场规模将达到57.0亿人民币，2024年至2033年的年复合增长率为40.8%。
Ventricular assist devices (VADs) are an important type of mechanical circulatory support (MCS) that assist the heart in pumping blood throughout the body. Depending on the clinical application, VADs can be divided into temporary and durable devices. Durable VADs are implantable ventricular assist devices (the main representative of implantable artificial hearts), which can meet patients' long-term circulatory support needs. They can serve as a bridging therapy to heart transplantation or cardiac rehabilitation, or as a long-term treatment option to replace cardiac function. From 2019 to 2024, affected by the COVID-19 pandemic, the global market size of implantable ventricular assist devices remained at around US$1 billion. From 2020 to 2024, the market size of implantable ventricular assist devices in my country increased from RMB 1 million to RMB 260 million, with a CAGR of 339.8%. It is projected that the market size of implantable ventricular assist devices in my country will reach RMB 5.7 billion by 2033, with a CAGR of 40.8% from 2024 to 2033.
